Tech Company Financing Transactions

Second Genome Funding Round

On 6/5/2013, Second Genome landed $6.5 million in Series A investment from Advanced Technology Ventures, Morgenthaler Ventures and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

341 Allerton Ave.
South San Francisco, CA 94080
USA

Phone

(650) 440-4606

Website

www.secondgenome.com

Email Address

[email protected]

Overview

Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Glenn Nedwin

        

Chief Medical Officer

Matthew McClure

        

Chief Scientific Officer

Karim Dabbagh

        

Vice President

Todd DeSantis

        

VP - Bus. Development

Anu Hoey

        

VP - Finance

Brian Dowd

        

VP - Human Resources

James Sjoerdsma

        

Browse more venture capital transactions:

Prev: 6/5/2013: Calient Technologies venture capital transaction
Next: 6/5/2013: Opanga Networks venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary